In a pre-launch clinical evaluation collecting postoperative clinical outcomes, RayOne Galaxy (n=52 eyes) showed a trend towards less halo and glare compared to published data on established diffractive IOLs at 1 month post-op.
Galaxy: Amon et al. the Ophthalmologist Supplement. 04 2025.
PanOptix: Adapted from Lwowski C et al. J Refract Surg. 2023 Aug; 39(8): 510-517.
AT LISA tri: Adapted from Kretz FT et al. J Refract Surg. 2015 Aug;31(8):504-10.